276 related articles for article (PubMed ID: 36421687)
1. Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis.
Nulali J; Zhan M; Zhang K; Tu P; Liu Y; Song H
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421687
[TBL] [Abstract][Full Text] [Related]
2. Vertebrate SLRP family evolution and the subfunctionalization of osteoglycin gene duplicates in teleost fish.
Costa RA; Martins RST; Capilla E; Anjos L; Power DM
BMC Evol Biol; 2018 Dec; 18(1):191. PubMed ID: 30545285
[TBL] [Abstract][Full Text] [Related]
3. Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4.
Qin W; Zhang J; Rong R; Zhang L; Gao H; Liu C; Ren Q; Zheng G; Wang J; Meng L; Qiao S; Qian R; Zhou C; Wang H; Zhang Y
Tissue Cell; 2022 Oct; 78():101867. PubMed ID: 35908351
[TBL] [Abstract][Full Text] [Related]
4. Small Leucine-Rich Proteoglycans (SLRPs) in the Retina.
Low SWY; Connor TB; Kassem IS; Costakos DM; Chaurasia SS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298915
[TBL] [Abstract][Full Text] [Related]
5. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
J Exp Clin Cancer Res; 2018 Mar; 37(1):41. PubMed ID: 29499765
[TBL] [Abstract][Full Text] [Related]
6. Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.
Xu T; Zhang R; Dong M; Zhang Z; Li H; Zhan C; Li X
Onco Targets Ther; 2019; 12():10639-10650. PubMed ID: 31824171
[TBL] [Abstract][Full Text] [Related]
7. Osteoglycin silencing exerts inhibitory effects on myocardial fibrosis and epithelial/endothelial-mesenchymal transformation in a mouse model of myocarditis.
Fang Y; Chang Z; Xu Z; Hu J; Zhou H; Yu S; Wan X
Biofactors; 2020 Nov; 46(6):1018-1030. PubMed ID: 33141515
[TBL] [Abstract][Full Text] [Related]
8. The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease?
Deckx S; Heymans S; Papageorgiou AP
FASEB J; 2016 Aug; 30(8):2651-61. PubMed ID: 27080639
[TBL] [Abstract][Full Text] [Related]
9. From Translation to Protein Degradation as Mechanisms for Regulating Biological Functions: A Review on the SLRP Family in Skeletal Tissues.
Zappia J; Joiret M; Sanchez C; Lambert C; Geris L; Muller M; Henrotin Y
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947880
[TBL] [Abstract][Full Text] [Related]
10. Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
Zuo C; Li X; Huang J; Chen D; Ji K; Yang Y; Xu T; Zhu D; Yan C; Gao P
Cardiovasc Res; 2018 Apr; 114(5):703-712. PubMed ID: 29415171
[TBL] [Abstract][Full Text] [Related]
11. Osteoglycin deficiency does not affect atherosclerosis in mice.
Moncayo-Arlandi J; López-García A; Fernández MC; Durán AC; Fernández B
Atherosclerosis; 2014 Dec; 237(2):418-25. PubMed ID: 25463067
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis.
Ge G; Seo NS; Liang X; Hopkins DR; Höök M; Greenspan DS
J Biol Chem; 2004 Oct; 279(40):41626-33. PubMed ID: 15292192
[TBL] [Abstract][Full Text] [Related]
13. The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.
Chen S; Birk DE
FEBS J; 2013 May; 280(10):2120-37. PubMed ID: 23331954
[TBL] [Abstract][Full Text] [Related]
14. Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease.
Christensen G; Herum KM; Lunde IG
Matrix Biol; 2019 Jan; 75-76():286-299. PubMed ID: 29337052
[TBL] [Abstract][Full Text] [Related]
15. Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.
Appunni S; Anand V; Khandelwal M; Gupta N; Rubens M; Sharma A
Clin Chim Acta; 2019 Apr; 491():1-7. PubMed ID: 30629950
[TBL] [Abstract][Full Text] [Related]
16. Analysis of transcriptional regulation of the small leucine rich proteoglycans.
Tasheva ES; Klocke B; Conrad GW
Mol Vis; 2004 Oct; 10():758-72. PubMed ID: 15496828
[TBL] [Abstract][Full Text] [Related]
17. Canine tissue-specific expression of multiple small leucine rich proteoglycans.
Yang CH; Culshaw GJ; Liu MM; Lu CC; French AT; Clements DN; Corcoran BM
Vet J; 2012 Aug; 193(2):374-80. PubMed ID: 22365843
[TBL] [Abstract][Full Text] [Related]
18. A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis.
Rienks M; Papageorgiou A; Wouters K; Verhesen W; Leeuwen RV; Carai P; Summer G; Westermann D; Heymans S
Cell Mol Life Sci; 2017 Apr; 74(8):1511-1525. PubMed ID: 27878326
[TBL] [Abstract][Full Text] [Related]
19. Small leucine-rich proteoglycans and matrix metalloproteinase-14: Key partners?
Pietraszek-Gremplewicz K; Karamanou K; Niang A; Dauchez M; Belloy N; Maquart FX; Baud S; Brézillon S
Matrix Biol; 2019 Jan; 75-76():271-285. PubMed ID: 29253518
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?
Radisky DC; Kenny PA; Bissell MJ
J Cell Biochem; 2007 Jul; 101(4):830-9. PubMed ID: 17211838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
